Investor Name | Lead Investor | Funding Round |
---|---|---|
Kite Pharma | Yes | Post-IPO Equity |
CAM Capital | Yes | Series C |
Aju IB Investment | Yes | Series B |
Quan Capital | Yes | Series B |
Adage Capital Management | - | Series C |
Asymmetry Ventures | - | Series C |
CaaS Capital Management | - | Series C |
Cambrian Biopharma | - | Series C |
Clough Capital Partners | - | Series C |
LG Technology Ventures | - | Series C |
JVC Investment Partners | - | Series B |
Mirae Asset Capital | - | Series B |
Mirae Asset Venture Investment | - | Series B |
New Enterprise Associates | - | Series B |
Novo Holdings | - | Series B |
Solasta Ventures | - | Series B |
SR One | - | Series B |
Takeda Ventures | - | Series B |
Novo Ventures | - | Series A |